Funds holding “Adaptive Biotechnologies Corp”
Which closed-end funds own a security? Searches the latest N-PORT snapshot of every active fund. Enter a ticker (issuer-level: matches the vendor-mapped ticker), a CUSIP or ISIN (security-level: one specific bond or share class), or part of a name.
3 positions across 3 funds, 2 distinct securities (bonds, share classes and derivatives of the same issuer are listed separately). Weights are percent of net assets from each fund’s latest N-PORT; report dates differ by fund.
| Fund | Position | Identifier | Type | Weight | Value (USD) | Report date | Coverage |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors Healthcare | Adaptive Biotechnologies Corp | 00650F109 | EC | 1.07% | $7.4M | Jun 30, 2026 | full (145 positions) |
| HQH abrdn Healthcare Investors Healthcare | Adaptive Biotechnologies Corp | 00650F109 | EC | 0.90% | $12.3M | Jun 30, 2026 | full (154 positions) |
| AVK Advent Convertible & Income Fund Convertible Securities | ADAPTIVE BIOTECHNOLOGIES CORP | 00650FAA7 | DBT | 0.19% | $1.4M | Jul 31, 2026 | full (466 positions) |
Matching position names
Adaptive Biotechnologies Corp · 2ADAPTIVE BIOTECHNOLOGIES CORP · 1
Historical holdings reports are not a real-time portfolio. Security-level matching (CUSIP/ISIN) distinguishes a company’s bonds, common shares, preferreds and derivatives; issuer-level matching groups them by name or ticker and is labelled as such. See the overlap tool to compare two portfolios.